Professor Xiao Xinhua: Diabetes and Endocrinology Specialist
Professor Xiao Xinhua is a senior endocrinologist, chief physician, professor, and doctoral supervisor at Peking Union Medical College Hospital (PUMCH). She also serves in the Chinese Academy of Medical Sciences Diabetes Research Center and holds professional leadership roles in diabetes medicine.
Her clinical and research work focuses on the mechanisms and early prevention of diabetes, the molecular genetics of uncommon forms of diabetes, and diabetes during pregnancy.
For an overview of the hospital, see our Peking Union Medical College Hospital international patient guide. Patients with osteoporosis, calcium imbalance, or parathyroid disease can also read our profile of Professor Xing Xiaoping.
Clinical Specialties
Professor Xiao’s principal areas include:
- type 1 and type 2 diabetes;
- young-onset diabetes;
- monogenic diabetes, including maturity-onset diabetes of the young;
- atypical or difficult-to-classify diabetes;
- diabetes during pregnancy;
- early detection and prevention of metabolic disease;
- family-based and genetic evaluation of diabetes; and
- second opinions when the diabetes type or treatment plan is uncertain.
Young-Onset and Atypical Diabetes
Diabetes diagnosed in childhood, adolescence, or early adulthood is not always type 1 diabetes. Some patients have type 2 diabetes, pancreatic disease, medication-related diabetes, an endocrine disorder, or a single-gene form of diabetes.
Correct classification matters because treatment, monitoring, family screening, and long-term risk may differ. A patient who is incorrectly classified may receive unnecessary insulin or may miss treatment better suited to the underlying cause.
Professor Xiao’s work includes the use of clinical features to distinguish common forms of maturity-onset diabetes of the young from type 1 diabetes in young Chinese patients.
Maturity-Onset Diabetes of the Young
Maturity-onset diabetes of the young, known as MODY, is a group of inherited forms of diabetes caused by a change in a single gene. It often appears at a young age and may affect several generations of the same family.
Two well-known forms involve the GCK and HNF1A genes. GCK-related diabetes often causes mild, stable fasting hyperglycemia and may not require routine medication outside pregnancy. HNF1A-related diabetes can progress over time and may respond strongly to certain oral medicines.
These patterns are not sufficient to make a diagnosis by themselves. Genetic testing may be recommended when the clinical history suggests monogenic diabetes, but results should be interpreted by an experienced team together with antibody tests, C-peptide, family history, and other findings.
Type 1 and Type 2 Diabetes
Type 1 diabetes results from autoimmune destruction of insulin-producing cells and usually requires lifelong insulin treatment. Type 2 diabetes involves insulin resistance and progressive impairment of insulin secretion, although its presentation can vary widely.
A specialist review may help when blood glucose remains unstable, severe hypoglycemia occurs, complications progress, weight or other metabolic factors complicate treatment, or laboratory findings do not fit the presumed diagnosis.
Treatment may include nutrition and activity planning, glucose monitoring, insulin, oral medicines, injectable therapies, or diabetes technology. The most appropriate combination depends on diagnosis, age, pregnancy status, kidney and heart health, risk of hypoglycemia, and patient preference.
Gestational Diabetes and Diabetes in Pregnancy
Gestational diabetes is first recognized during pregnancy and can increase risks for both mother and baby. Patients with pre-existing type 1, type 2, or monogenic diabetes also require careful planning before and during pregnancy.
Professor Xiao’s work includes the study of glucose abnormalities during pregnancy and the influence of early-life metabolic exposure on later health.
Management may involve individualized glucose targets, nutrition therapy, home monitoring, insulin when needed, fetal assessment, and postpartum testing. Patients planning pregnancy should review medicines in advance because some diabetes and blood-pressure treatments are not appropriate during pregnancy.
Early Prevention and Life-Course Metabolic Health
Professor Xiao has participated in large clinical cohort research on early warning and intervention for abnormal glucose metabolism. This work examines how genetic factors, pregnancy, childhood development, lifestyle, and other exposures may influence future diabetes risk.
Prevention recommendations should be evidence-based and realistic. They may include weight management, physical activity, nutrition changes, sleep improvement, and monitoring of individuals at increased risk. Prevention does not eliminate genetic risk, and unexplained symptoms still require medical evaluation.
Research and Academic Contributions
Professor Xiao’s representative research includes clinical methods for distinguishing GCK-MODY and HNF1A-MODY from type 1 diabetes in younger Chinese patients. She has also led research related to the early origins and prevention of glucose metabolic disease.
Genetic and cohort research can improve diagnosis and prevention, but it does not replace individualized clinical assessment. Genetic findings may also have implications for relatives and should be discussed with appropriate counseling.
Who May Consider a Consultation?
A consultation with Professor Xiao or the PUMCH endocrinology team may be worth considering when a patient:
- developed diabetes at a young age but the type remains uncertain;
- has a strong family history across several generations;
- has mild fasting hyperglycemia that has remained stable for years;
- was diagnosed with type 1 diabetes but retains significant insulin production;
- has negative autoimmune antibody tests or an unusual response to treatment;
- is planning pregnancy or has diabetes during pregnancy;
- has difficult glucose control, repeated hypoglycemia, or treatment complications; or
- needs a second opinion before genetic testing or a major treatment change.
Medical Records to Prepare
International patients should prepare:
- a concise medical summary and timeline from the first abnormal glucose result;
- fasting glucose, post-meal glucose, and HbA1c trends;
- C-peptide and insulin results with the corresponding glucose level;
- GAD, IA-2, ZnT8, and other diabetes antibody results when available;
- continuous glucose monitor or home glucose records;
- genetic testing reports and raw variant information when available;
- a family tree showing relatives with diabetes and their age at diagnosis;
- pregnancy records and glucose tolerance test results when relevant;
- kidney, liver, eye, nerve, and cardiovascular complication assessments;
- a complete list of current and previous diabetes medicines, doses, response, and side effects; and
- a clear list of questions for the specialist.
Planning an International Consultation
Appointments with senior specialists may be limited. Before traveling, patients should confirm whether records can be reviewed, whether an in-person examination is required, and which laboratory or genetic tests may need to be repeated.
Remote medical-record review is subject to physician authorization. It may help clarify the next step, but diagnosis and treatment decisions may still require in-person assessment, especially during pregnancy or when diabetes is unstable.
How CMCS Can Assist
CMCS – China Medical Concierge Shanghai is an independent medical concierge and health management company, not a hospital. We assist international patients with organizing and translating medical records, identifying an appropriate specialist, requesting appointment availability, arranging interpretation, and planning medical travel in China.
Access to Professor Xiao, remote review, genetic testing, or any particular treatment is subject to the doctor’s and hospital’s approval. CMCS does not guarantee appointments, treatment eligibility, or clinical outcomes.
For assistance, contact CMCS:
- Email: contract@medicalsh.com
- WhatsApp: Contact us on WhatsApp
- Website: www.medicalsh.com
Important Note
Doctor titles, clinical roles, research activities, test availability, and appointment arrangements may change. Patients should confirm current information before travel. This profile is based on publicly available hospital and academic sources and is provided for general information only. It is not individual medical advice and does not replace assessment by a qualified endocrinologist.
0件のコメント